Literature DB >> 28391651

Identification of a heterozygous p.Gly568Val missense mutation in the TRPV3 gene in a Japanese patient with Olmsted syndrome: In silico analysis of TRPV3.

Hiroshi Nagai1, Yutaka Takaoka2, Aki Sugano2, Yuji Nakamachi3, Seiji Kawano4, Chikako Nishigori1.   

Abstract

Olmsted syndrome is a very rare congenital disorder, characterized by palmoplantar keratoderma and periorificial keratotic lesions. Recently, TRPV3 was reported to be a causative gene of Olmsted syndrome. We identified a heterozygous missense mutation of TRPV3, c.1703G>T, p.Gly568Val, in a Japanese patient with Olmsted syndrome. To the best of our knowledge, this is the first report of a Japanese patient with Olmsted syndrome harboring a missense mutation in TRPV3. We conducted in silico analysis of TRPV3 to evaluate whether the p.Gly568Val leads to structural changes in the TRPV3 selectivity filter. The selectivity filter was shown to become dilated and hyperpermeable as a result of genetic mutation (p.Gly573Ser, p.Tr692Gly or p.Gly568Val) as well as after a change in temperature (300 K to 310 K). In silico analysis of TRPV3 could be a useful approach in predicting mutation-induced activated states of ion channels, and thus enrich our understanding of the pathogenesis of Olmsted syndrome.
© 2017 Japanese Dermatological Association.

Entities:  

Keywords:  Olmsted syndrome; TRPV3; in silico analysis; mutation; selectivity filter

Mesh:

Substances:

Year:  2017        PMID: 28391651     DOI: 10.1111/1346-8138.13844

Source DB:  PubMed          Journal:  J Dermatol        ISSN: 0385-2407            Impact factor:   4.005


  7 in total

1.  Co-precipitation molecules hemopexin and transferrin may be key molecules for fibrillogenesis in TTR V30M amyloidogenesis.

Authors:  Mika Ohta; Aki Sugano; Naoya Hatano; Hirotaka Sato; Hirofumi Shimada; Hitoshi Niwa; Toshiyuki Sakaeda; Hajime Tei; Yoshiyuki Sakaki; Ken-Ichi Yamamura; Yutaka Takaoka
Journal:  Transgenic Res       Date:  2017-12-29       Impact factor: 2.788

2.  Olmsted Syndrome Caused by a Heterozygous p.Gly568Val Missense Mutation in TRPV3 Gene.

Authors:  Ji Young Choi; Song Ee Kim; Sang Eun Lee; Soo Chan Kim
Journal:  Yonsei Med J       Date:  2018-03       Impact factor: 2.759

3.  Identification of Transient Receptor Potential Vanilloid 3 Antagonists from Achillea alpina L. and Separation by Liquid-Liquid-Refining Extraction and High-Speed Counter-Current Chromatography.

Authors:  Shi-Wei Sun; Rong-Rong Wang; Xiao-Ying Sun; Jia-He Fan; Hang Qi; Yang Liu; Guo-Qing Qin; Wei Wang
Journal:  Molecules       Date:  2020-04-26       Impact factor: 4.411

4.  Establishment of the experimental procedure for prediction of conjugation capacity in mutant UGT1A1.

Authors:  Yutaka Takaoka; Atsuko Takeuchi; Aki Sugano; Kenji Miura; Mika Ohta; Takashi Suzuki; Daisuke Kobayashi; Takuji Kimura; Juichi Sato; Nobutaro Ban; Hisahide Nishio; Toshiyuki Sakaeda
Journal:  PLoS One       Date:  2019-11-15       Impact factor: 3.240

5.  Transient receptor potential vanilloid 3 expression is increased in non-lesional skin of atopic dermatitis patients.

Authors:  Nikolett Vasas; Zsófia Pénzes; Kornél Kistamás; Péter Pál Nánási; Szabolcs Molnár; Andrea Szegedi; Attila Gábor Szöllősi; Tamás Bíró
Journal:  Exp Dermatol       Date:  2022-02-04       Impact factor: 4.511

6.  Hair Loss Caused by Gain-of-Function Mutant TRPV3 Is Associated with Premature Differentiation of Follicular Keratinocytes.

Authors:  Zhongya Song; Xi Chen; Qian Zhao; Vesna Stanic; Zhimiao Lin; Shuxia Yang; Ting Chen; Jiang Chen; Yong Yang
Journal:  J Invest Dermatol       Date:  2021-03-03       Impact factor: 7.590

Review 7.  TRP Channels as Drug Targets to Relieve Itch.

Authors:  Zili Xie; Hongzhen Hu
Journal:  Pharmaceuticals (Basel)       Date:  2018-10-06
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.